1. Home
  2. Browse
  3. Cardiology
  4. Heart Failure
  5. Drug-Induced Heart Failure

Drug-Induced Heart Failure

46 - 60 of 64 Results
Sort Results:
PL Voices: Gliptins and Cardiovascular Risk November 2013
PL Voices: Preventing Heart Failure Hospital Admissions November 2013
Guideline: The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure November 2013
PL Voices: Combining Antiplatelet Drugs with Anticoagulants November 2013
Guideline: 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines November 2013
Patient Education: Heart Failure Meds and More October 2013
Article: you'll hear MORE controversy about using pioglitazone (Actos, etc) for type 2 diabetes October 2012
PL Voices: Concerns About Pioglitazone (Actos) and Bladder Cancer October 2012
Commentary: Glitazones and the Risk of Bladder Cancer October 2012
Article: how to handle drug-induced edema November 2011
Article: Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted December 2010
Commentary: Restricted Use of Rosiglitazone Products (Avandia, Avandamet, and Avandaryl) December 2010
Article: whether Avandia is riskier than Actos August 2010
Other: See new Health Canada information concerning the restricted use of Avandia August 2010
Commentary: Cardiovascular Safety of Rosiglitazone (Avandia) – 2010 Update August 2010